Status:
COMPLETED
Human Irisin Concentration in Sarcopenia
Lead Sponsor:
Korea University
Conditions:
Sarcopenia
Eligibility:
All Genders
20-80 years
Brief Summary
Irisin has been identified as a novel myokine that drives brown-fat-like conversion of white adipose tissue. In this cross-sectional study, the researches investigated whether serum irisin levels are ...
Eligibility Criteria
Inclusion
- 20\<age\<80
- apparently healthy subjects
Exclusion
- a history of cardiovascular disease
- diabetes
- stage 2 hypertension
- malignancy
- severe renal or hepatic disease
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
406 Patients enrolled
Trial Details
Trial ID
NCT01874912
Start Date
November 1 2009
End Date
April 1 2011
Last Update
June 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Guro Hospital
Seoul, South Korea